Knowledge of human papillomavirus and its vaccine in parents of Rivera, Huila in 2015
PDF (Español (España))
HTML (Español (España))

Keywords

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Patient Acceptance of Health Care
Parents
Knowledge
Colombia

How to Cite

Torrado-Arenas, D. M., Álvarez-Pabón, Y., González-Castañeda, J. L., Rivera-Contreras, O. E., Sosa-Vesga, C. D., González, B. X., & Sepúlveda-Agudelo, J. (2017). Knowledge of human papillomavirus and its vaccine in parents of Rivera, Huila in 2015. Médicas UIS, 30(1), 13–19. https://doi.org/10.18273/revmed.v30n1-2017001

Abstract

Human Papillomavirus Vaccine is the most recent and controversial step for cervical cancer prevention. During 2014, in Colombia, a series of suspected adverse reactions to the vaccine caused a decline in its coverage. Objective: the aim of this study is to describe the knowledge about Human Papillomavirus and its vaccine from parents of Rivera, Huila. Materials and method: cross-sectional study with a convenient sample of 124 parents whose children were under 18 years old; through a socio-demographic questionnaire, knowledge about issues related to the virus, related to cervical cancer and its vaccine was measured. A quantitative analysis was performed by simple frequency analysis. Results: the level of knowlodge was low (44,35%); 43,54% of the parents identify Human Papillomavirus as an etiological cervical cancer agent, just 7,4% of the parents consider the vaccine as an useful preventive method and the vaccine was accepted by 87% of the parents. Conclusions: the knowledge level of the parents of Rivera, Huila about Human Papillomavirus and cervical cancer is low and it is affected by the ignorance of the different cervical cancer preventive strategies, as well as the lack of information of the action of Human Papillomavirus vaccine. However, the vaccine acceptability is high. MÉD.UIS. 2017;30(1):13-9.

Keywords: Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18. Patient Acceptance of Health Care. Parents. Knowledge. Colombia

https://doi.org/10.18273/revmed.v30n1-2017001
PDF (Español (España))
HTML (Español (España))

References

Soto-De Leon S, Camargo M, Sanchez R, Munoz M, Perez-

Prados A, Purroy A, et al. Distribution patterns of infection

with multiple types of human papillomaviruses and their

association with risk factors. PLoS One. 2011;6(2):1–7.

Instituto Nacional de Cancerología E.S.E; Instituto Geográfico

Agustín Codazzi (IGAC). Atlas de mortalidad por cáncer en

Colombia / Instituto Nacional de Cancerología; IGAC. 3 ed.

Bogotá, Colombia, 2010.

Secretaria Municipal de Salud de Rivera. Análisis de situación

de salud con el modelo de los determinantes sociales de salud

municipio de rivera 2014. Rivera, Huila; 2014 p. 1-179.

Bermedo-Carrasco S, Xin C, Peña-Sánchez JN, Lepnurm R.

Predictors of having heard about human papillomavirus

vaccination: Critical aspects for cervical cancer prevention

among Colombian women. Gac Sanit. 2015;29(2):112–7.

Ministerio De La Protección, OPS/OMS Colombia. Cruzada

interminable por la niñez colombiana historia del programa

ampliado de inmunizaciones, PAI, en Colombia, 1979-2009.

Bogotá, Colombia: Luis Fernando Jaramillo Ángel; 2010 p. 334.

Gutiérrez W. La vacuna contra el virus del papiloma humano:

algunas precisiones. Rev Peru Med Exp Salud Publica. 2011;28(4):688–99.

Blödt S, Holmberg C, Müller-Nordhorn J, Rieckmann N.

Human Papillomavirus awareness, knowledge and vaccine

acceptance: a survey among 18-25 year old male and female

vocational school students in Berlin, Germany. Eur J Public

Health. 2012;22(6):808–13.

Ministerio de Salud y Protección Social. Colombia cuenta

con las mejores coberturas de vacunación contra VPH del

mundo [Internet]. Colombia, 2014 [citado 10 de febrero de

. Disponible en: https://www.minsalud.gov.co/Paginas/

Colombia-cuenta-con-las-mejores-coberturas-de-vacunacion.

aspx.

Torrecilla MA, Pedregal M, García F, Ruiz J. Efectos adversos

de la vacunación contra el virus del papiloma humano. Aten

Primaria. 2011;43(1):5–10.

Gonçalves AK, Cobucci RN, Rodrigues HM, de Melo AG,

Giraldo PC. Safety, tolerability and side effects of human

papillomavirus vaccines: a systematic quantitative review.

Braz J Infect Dis. 2014;18(6):651–9.

Lu B, Kumar A, Castellsagué X, Giuliano AR. Efficacy and

safety of prophylactic vaccines against cervical HPV infection

and diseases among women: a systematic review & metaanalysis.

BMC Infect Dis. 2011;11:13.

Wong MC, Lee A, Ngai K, Chor JC, Chan PK. Knowledge,

attitude, practice and barriers on vaccination against human

papillomavirus infection: a cross-sectional study among primary

care physicians in Hong Kong. PLoS One. 2013;8(8):1–10.

Haug CJ. Human Papillomavirus Vaccination- Reasons for

Caution. N Engl J Med. 2008;359(8):861-862.

Forero A. Caso de niñas del Carmen de Bolívar desplomó

vacunación contra el VPH. El Tiempo [periódico en internet].

Colombia, 2015 [citado en febrero de 2016]. Disponible en:

http://m.eltiempo.com/estilo-de-vida/salud/caso-de-ninasdel-

carmen-de-bolivar-desplomo-vacunacion-contra-elvph/

/1/home.

Dirección General Instituto Nacional de Salud Colombia.

Informe de estudio de brote del evento de interés en salud

pública de etiología desconocida, municipio de El Carmen

de Bolívar, Bolívar, 2014. Presentation presented at; 2014;

Colombia.

Wiesner C, Piñeros M, Trujillo LM, Cortés C, Ardila J.

Aceptabilidad de la vacuna contra el Virus Papiloma Humano

en padres de adolescentes, en Colombia. Rev Salud Pública.

;12(6):961–73.

Kose D, Erkorkmaz U, Cinar N, Altinkaynak S. Mothers’

knowledge and attitudes about HPV vaccination to prevent

cervical cancers. Asian Pac J Cancer Prev. 2014;15(17):7263–6.

Giambi C, D’Ancona F, Del Manso M, De Mei B, Giovannelli I,

Cattaneo C, et al. Exploring reasons for non-vaccination against

human papillomavirus in Italy. BMC Infect Dis. 2014;14:545.

Dursun P, Altuntas B, Kuscu E, Ayhan A. Women’s knowledge

about human papillomavirus and their acceptance of HPV

vaccine. Aust New Zeal J Obstet Gynaecol. 2009;49(2):202–6.

Hanley SJ, Yoshioka E, Ito Y, Konno R, Sasaki Y, Kishi R, et al.

An exploratory study of Japanese fathers’ knowledge of and

attitudes towards HPV and HPV vaccination: does marital

status matter?. Asian Pac J Cancer Prev. 2014;15(4):1837–43.

Godoy MK, Zonana A, Anzaldo MC. Aceptación de la vacuna

contra el virus del papiloma humano por parte de madres

de hijas entre 9 y 13 años de edad. Ginecol Obstet Mex.

;81(11):645–51.

Cordeiro G, Pérez S, Iñarrea A, Simón D, Reboredo C, Couceiro

E, et al. ¿Por qué no se vacunan nuestras pacientes? Motivos

por los que las pacientes fuera de los programas de vacunación

sistemática, con infección por el virus del Papiloma Humano,

deciden decir no a la vacuna. Rev Chil Obstet Ginecol. 2014;79(5):390–95.

Portero-Alonso A, Alguacil-Ramos AM, Martín-Ivorra R,

Pastor-Villalba E, Lluch-Rodrigo JA. Conocimientos, creencias

y actitudes de los adolescentes sobre la vacuna del virus del

papiloma humano en la Comunidad Valenciana. Vacunas.

;13(1):7–14.

Urrutia MT, Concha X, Riquelme G, Padilla O. [Knowledge and

preventive behaviors related to cervical cancer and human

papiloma virus in a group of Chilean adolescents]. Rev Chilena

Infectol. 2012:29(6):600–6.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2017 Médicas UIS

Downloads

Download data is not yet available.